Could Amgen’s latest bad news boost their interest in acquisitions? — Senators urge FTC to scrutinize pharma mega-mergers — Merck’s Keytruda combo wins simultaneous approvals in US, Canada, and Australia — See more on our front page newsDismiss Notice
TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.Dismiss Notice
Discussion in 'Pharma Contract Manufacturing - General Discussion' started by Anonymous, Nov 7, 2013 at 1:57 AM.
Tags: Add Tags